MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1136/rmdopen-2022-002639

Медицинская библиотека · RMD open · 2022

Pausing methotrexate prevents impairment of Omicron BA.1 and BA.2 neutralisation after COVID-19 booster vaccination.

Habermann Elisa, Gieselmann Lutz, Tober-Lau Pinkus, Klotsche Jens, Albach Fredrik Nils, Ten Hagen Alexander, Zernicke Jan, Ahmadov Elvin, Arumahandi de Silva Amanthi Nadira, Frommert Leonie Maria, Kurth Florian, Sander Leif Erik, Burmester Gerd R, Klein Florian, Biesen Robert

СтатьяНаблюдательное исследованиеПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

OBJECTIVE

The level of neutralising capacity against Omicron BA.1 and BA.2 after third COVID-19 vaccination in patients on paused or continuous methotrexate (MTX) therapy is unclear.

METHODS

In this observational cohort study, neutralising serum activity against SARS-CoV-2 wild-type (Wu01) and variant of concern Omicron BA.1 and BA.2 were assessed by pseudovirus neutralisation assay before, 4 and 12 weeks after mRNA booster immunisation in 50 rheumatic patients on MTX, 26 of whom paused the medication. 44 non-immunosuppressed persons (NIP) served as control group.

RESULTS

While the neutralising serum activity against SARS-CoV-2 Wu01 and Omicron variants increased 67-73 fold in the NIP after booster vaccination, the serum activity in patients receiving MTX increased only 20-23 fold. Patients who continued MTX treatment during vaccination had significantly lower neutralisation against all variants at weeks 4 and 12 compared with patients who paused MTX and the control group, except for BA.2 at week 12. Patients who paused MTX reached comparably high neutralising capacities as NIP, except for Wu01 at week 12. The duration of the MTX pause after-not before-was associated with a significantly higher neutralisation capacity against all three variants, with an optimal duration at 10 days after vaccination.

CONCLUSION

Patients pausing MTX after COVID-19 booster showed a similar vaccine response to NIP. Patients who continued MTX demonstrated an impaired response indicating a potentially beneficial second booster vaccination. Our data also suggest that a 1 week MTX break is sufficient if the last administration of MTX occurs 1-3 days before vaccination.

Для цитирования: Habermann Elisa, Gieselmann Lutz, Tober-Lau Pinkus, Klotsche Jens, Albach Fredrik Nils, Ten Hagen Alexander, Zernicke Jan, Ahmadov Elvin, Arumahandi de Silva Amanthi Nadira, Frommert Leonie Maria, Kurth Florian, Sander Leif Erik, Burmester Gerd R, Klein Florian, Biesen Robert. Pausing methotrexate prevents impairment of Omicron BA.1 and BA.2 neutralisation after COVID-19 booster vaccination.. RMD open. 2022. DOI: 10.1136/rmdopen-2022-002639.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.